STOCK TITAN

Omada Health CEO Sean P. Duffy sells 12,944 shares

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4

Rhea-AI Filing Summary

Omada Health, Inc. CEO Sean P. Duffy exercised options covering 12,944 shares on November 4, 2026, at an exercise price of $5.82 per share, acquired 12,944 common shares and sold 12,944 shares at a weighted-average price of $19.2159 per share. The acquisition and sale were reported under a Rule 10b5-1 plan adopted March 13, 2026; the transactions occurred automatically and were not discretionary. After the exercise, the reported option position covered 103,651 shares and expires August 21, 2029.

Insider Duffy Sean P.
Role Chief Executive Officer
Sold 12,944 shs ($249K)
Approx. gross sale proceeds $249K
Approx. exercise cost $75K
Approx. pre-tax spread $173K
Share of Position Sold 3.3%
Type Security Shares Price Value
Exercise Stock Option (Right to Buy) F4 12,944 $0.00 $0.00
Exercise Common Stock F1 12,944 $5.82 $75K
Sale Common Stock F1, F2 12,944 $19.2159 $249K
Holding Common Stock F3 -- -- --
Holdings After Transaction: Stock Option (Right to Buy) — 103,651 options (Direct); Common Stock — 382,594 shares (Direct); Common Stock — 851,659 shares (Indirect, See footnote)
Holdings Before and After: Stock Option (Right to Buy), 116,595 to 103,651 options (Direct); Common Stock, 382,594 to 382,594 shares (Direct)
Footnotes (4)
  1. F1. Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The transaction occurred automatically and does not represent a discretionary transaction by the Reporting Person.
  2. F2. This transaction was executed in multiple trades at prices ranging from $19.11 to $19.50. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  3. F3. Held in family trusts for the benefit of the Reporting Person's family members. The Reporting Person disclaims beneficial ownership of the shares held by the family trusts except to the extent of his pecuniary interest therein.
  4. F4. 100% of the shares subject to the option are fully vested and exercisable.
Shares acquired through option exercise 12,944 shares November 4, 2026
Option exercise price $5.82 per share Options exercised November 4, 2026
Shares sold 12,944 shares November 4, 2026
Weighted-average sale price $19.2159 per share Multiple trades on November 4, 2026
Sale price range $19.11 to $19.50 per share Multiple trades on November 4, 2026
Shares subject to option position after exercise 103,651 shares Option expiration: August 21, 2029
Common shares held in family trusts 851,659 shares Held for the benefit of the reporting person's family members
10b5-1 trading plan regulatory
"pursuant to a 10b5-1 trading plan adopted"
A 10b5-1 trading plan is a pre-arranged strategy that allows company insiders to buy or sell company stock at set times, regardless of their current knowledge about the company's situation. It acts like a scheduled appointment for trading, helping prevent the appearance of impropriety or insider trading. This plan provides a way for insiders to sell or buy shares in a controlled, transparent manner, offering reassurance to investors about fair trading practices.
weighted average price financial
"price reported above reflects the weighted average price"
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
fully vested and exercisable technical
"shares subject to the option are fully vested and exercisable"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many OMDA shares did Sean P. Duffy sell, and at what price?

Sean P. Duffy sold 12,944 shares on November 4, 2026, at a weighted-average price of $19.2159 per share. The sale was executed in multiple trades ranging from $19.11 to $19.50 under a Rule 10b5-1 plan adopted March 13, 2026, and occurred automatically.

How many OMDA shares were reported in Sean P. Duffy's family trusts?

851,659 common shares were reported as held in family trusts for the benefit of Sean P. Duffy's family members. He disclaimed beneficial ownership of those shares except to the extent of his pecuniary interest in them.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Duffy Sean P.

(Last)(First)(Middle)
C/O OMADA HEALTH, INC.
611 GATEWAY BLVD, SUITE 120

(Street)
SOUTH SAN FRANCISCO CALIFORNIA 94080

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Omada Health, Inc. [ OMDA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
Chief Executive Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
11/04/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock11/04/2026M(1)12,944A$5.82395,538D
Common Stock11/04/2026S(1)12,944D$19.2159(2)382,594D
Common Stock851,659ISee footnote(3)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right to Buy)$5.8211/04/2026M12,944 (4)08/21/2029Common Stock12,944$0103,651D
Explanation of Responses:
1. Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The transaction occurred automatically and does not represent a discretionary transaction by the Reporting Person.
2. This transaction was executed in multiple trades at prices ranging from $19.11 to $19.50. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
3. Held in family trusts for the benefit of the Reporting Person's family members. The Reporting Person disclaims beneficial ownership of the shares held by the family trusts except to the extent of his pecuniary interest therein.
4. 100% of the shares subject to the option are fully vested and exercisable.
/s/ Nathan Salha, as Attorney-in-Fact for Sean P. Duffy11/06/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading